Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Mind Altering Conversations with Mauro Cavara, featuring Steven Fülle
Check out the FIRST episode of our podcast series, MIND ALTERING CONVERSATIONS! In this series, psychedelic science student Steven Fülle talks to Dr. Mauro Cavara about his research into psilocybin being used for pain management in fibromyalgia.
Watch it here!
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to the NEW Dr. Elisabeth Prevete!
On successfully defending her PhD thesis ‘Mental Effects and Potential Therapeutic Use of Kratom/Mitragynine!’ This project was a joint venture between Maastricht University and Sapienza University of Rome. This is Elisabeth’s SECOND doctorate, she now holds an MD and a PhD! Congrats once again Elisbath on a great accomplishment!
Watch the defense here!
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Conny Quaedflieg
EEG, Stress Resilience, Intentional Forgetting
Through my extensive research experience, I have built expertise in various disciplines (psychology, psychophysiology, neurosciences) and I have become enthusiastic about bridging them.
Sarah Roche, MSc
Sustainability, Psilocybin, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Simon Neugebauer, MSc
Affective Bias, Psychedelics, Plasticity
I specifically investigate how psychedelics can be used to pharmacologically probe and treat a negative affect biotype, that characterizes many emotional disorders.
Dr. Natasha Mason
Psychedelics, Neuroadaptations, Plasticity
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Prof. Arjan Blokland
Learning & Memory, Acetylcholine, Cognition
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Dr. Eline Haijen
Psychedelics, ADHD, Microdosing
I am a post doctoral researcher in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
Dr. Kim Kuypers
Microdosing, Cognition, Nutrition
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
Psychedelic Research
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life
5-MeO-DMT, naturalistic, psychopathological
→
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
→
Trait mindfulness and personality characteristics in a microdosing ADHD sample: a naturalistic prospective survey study
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Glutamate, Functional Connectivity, Cannabis
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.